Skip to main content
. 2012 Jul 7;471(1):244–249. doi: 10.1007/s11999-012-2469-2

Table 3.

Mean tissue concentrations of cefazolin at each sample point

Intraosseous Systemic
Time (minutes; ± SD) Mean concentration (μg/g; ± SD) 95% CI (μg/g) Time (minutes; ± SD) Mean concentration (μg/g; ± SD) 95% CI (μg/g)
Sample point
Subcutaneous fat 1 1.2 175.3 102–250 1.3 7.2 4.2–10.3
(0.6) (110) (0.4) (4.3)
Subcutaneous fat 2 11 193.0 140–247 14 12.8 8.4–17.2
(5.1) (79.8) (6.6) (6.6)
Subcutaneous fat 3 30 206.3 121–292 35 11.2 8.4–14.0
(11.1) (127) (12.3) (4.1)
Subcutaneous fat 4 56 169.1 88–250 54 11.3 7.1–15.4
(23.2) (120) (17.3) (6.2)
Bone sample 1 11 75.4 26–125 14 9.2 7.4–10.9
(5.1) (74.2) (6.6) (2.6)
Bone sample 2 30 165.6 21–311 35 14.1 8.6–19.6
(11.1) (216) (12.3) (8.2)
Bone sample 3 56 148.8 79–219 54 10.8 7.7–13.8
(23.2) (105) (17.3) (4.6)

Times are given as minutes postsurgical incision. Differences in mean tissue concentrations between the two groups were statistically significant (p < 0.001) for all comparison points.